Amphastar Pharma Business Finance Contracts & Agreements
42 Contracts & Agreements
- Credit Agreements (6 contracts)
- Escrow Agreements (1)
- Exchange Agreements (1)
- Guarantee Agreements (1)
- Indenture Agreements (1)
- Investment Agreements (2)
- Loan Agreements (10)
- Modification Agreements (1)
- Note Agreements (1)
- Purchase Agreements (3)
- Registration Rights Agreements (1)
- Repurchase Agreements (1)
- Share Agreements (1)
- Stock Agreements (4)
- Subscription Agreements (7)
- Underwriting Agreements (1)
- Purchase Agreement, dated September 12, 2023, among Amphastar Pharmaceuticals, Inc. and Jefferies LLC, J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and BofA Securities,... (Filed With SEC on September 15, 2023)
- Indenture, dated September 15, 2023, between Amphastar Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on September 15, 2023)
- Asset Purchase Agreement by and among Amphastar Pharmaceuticals, Inc., Amphastar Medication Co., LLC, and Eli Lilly and Company, dated April 21, 2023 (Filed With SEC on August 9, 2023)
- Share Repurchase Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc., Nanjing Qianqia Enterprise Management Consulting (LLP), Nanjing Zhongpan Enterprise Management... (Filed With SEC on August 9, 2021)
- Share Purchase Agreement by and between Amphastar Pharmaceuticals, Inc., Nanjing Zhongpan Enterprise Management Consulting Center (LLP), Nanjing Zhanrun Enterprise Management... (Filed With SEC on August 9, 2021)
- Eight Modification to the Revolving Line of Credit Agreement, dated March 7, 2016, between International Medication Systems, Limited and East West Bank in the principal sum of... (Filed With SEC on March 15, 2021)
- Equipment Line of Credit, dated September 1, 2020, between International Medication Systems, Limited and East West Bank in the original sum of $10,000,000 (Filed With SEC on November 6, 2020)
- Eighth Modification to the Revolving Line of Credit Agreement, dated June 15, 2020, between Amphastar Pharmaceuticals, Inc. and Armstrong Pharmaceuticals, Inc. and Cathay Bank in... (Filed With SEC on August 10, 2020)
- Ninth Amendment to the Acquisition Loan, dated July 19, 2019 between Amphastar Pharmaceuticals, Inc. and Cathay Bank (Filed With SEC on August 9, 2019)
- Equipment Line of Credit, dated January 8, 2019, between International Medication Systems, Limited and East West Bank in the original principal sum of $10,000,000 (Filed With SEC on May 10, 2019)
- First Modification to the Loan Agreement, dated April 22, 2019, between Amphastar Pharmaceuticals, Inc. and Cathay Bank (Filed With SEC on May 10, 2019)
- Subscription Agreement between Amphastar Cayman, LLC and KYW Investment partnership dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Yu-Chieh W. Lee dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Chieh-Lin J. Lee dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Stephen B. Shohet dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Yakob Liawatidewi dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Rong Zhou dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and William J. Peters dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Jason B. Shandell dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Business Loan Agreement, dated August 14, 2017, between Armstrong Pharmaceuticals, Inc. and Cathay Bank in the original principal sum of $7,865,000 (Filed With SEC on November 9, 2017)
- Equipment Line of Credit, dated June 28, 2017, between International Medication Systems, Limited and East West Bank in the original principal sum of $8,000,000 (Filed With SEC on August 9, 2017)
- Sixth Modification to the Revolving Line of Credit Agreement, dated May 3, 2017, between International Medication Systems, Limited and East West Bank in the principal sum of... (Filed With SEC on August 9, 2017)
- Business Loan Agreement, dated May 18, 2017, between Amphastar Pharmaceuticals, Inc. and East West Bank in the original principal sum of $9,000,000 (Filed With SEC on August 9, 2017)
- Business Loan Agreement, dated May 11, 2017, between International Medication Systems, Limited and East West Bank in the original principal sum of $5,000,000 (Filed With SEC on August 9, 2017)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION SECOND... (Filed With SEC on March 15, 2017)
- BUSINESS LOAN AGREEMENT (Filed With SEC on November 9, 2016)
- FOURTH MODIFICATION AGREEMENT (Filed With SEC on August 9, 2016)
- CORPORATE RESOLUTION TO GRANT COLLATERAL / GUARANTEE (Filed With SEC on May 10, 2016)
- BUSINESS LOAN AGREEMENT (Filed With SEC on March 15, 2016)
- AMPHASTAR PHARMACEUTICALS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 18, 2014)
- PROMISSORY NOTE (Filed With SEC on May 20, 2014)
- LOAN AGREEMENT (Filed With SEC on May 20, 2014)
- ASSET PURCHASE AGREEMENT (LONG FORM) AMONG DIOSYNTH FRANCE (AS SELLER) AMPHASTAR FRANCE PHARMACEUTICALS SAS (AS BUYER) AND SCHERING-PLOUGH April 30, 2014 (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 20, 2014)
- Agreement Concerning Investment of Amphastar Nanjing Pharmaceuticals Co., Ltd. in Innovative Electronic Medical Equipment Project Date: July 5, 2010 Location: Nanjing (Filed With SEC on May 20, 2014)
- STANDARD OFFER, AGREEMENT AND ESCROW INSTRUCTIONS FOR PURCHASE OF REAL ESTATE (Non-Residential) AIR Commercial Real Estate Association (Filed With SEC on May 20, 2014)
- REGISTRATION RIGHTS AGREEMENT Dated as of February 4, 2005 between AMPHASTAR PHARMACEUTICALS, INC. and LOTUS CHINA FUND, L.P. (Filed With SEC on May 20, 2014)
- BUSINESS LOAN AGREEMENT (Filed With SEC on May 20, 2014)
- BUSINESS LOAN AGREEMENT (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. Deferred Stock Unit Notice of Grant (Filed With SEC on May 20, 2014)